No longer listed
Ezetimibe and rosuvastatin
Ezetimibe and rosuvastatin (Roszet) is not listed for sale in FDA's NDC Directory as read on October 8, 2026, and openFDA carries no current label for it; that is a listing status, not a ban or a recall. Drugs@FDA keeps 1 application on record, the first approved on March 23, 2021.
- Not listed for sale
What do the FDA files say?
A medicine leaves the NDC Directory when its makers stop listing it for sale. Its application history stays in Drugs@FDA.
| Application | Type | Sponsor (as Drugs@FDA abbreviates it) | Approved | Status |
|---|---|---|---|---|
| NDA213072 | NDA | Althera Pharms | March 23, 2021 | Not marketed |
Every label DailyMed keeps for ezetimibe and rosuvastatin, archived versions included
Source: FDA NDC Directory and Drugs@FDA (openFDA bulk files, October 8, 2026)
What next?
- Medicines A to Z
- every medicine the FDA lists
- Compare two medicines
- labels, generics and prices side by side